首页> 外文期刊>The Journal of toxicological sciences >Detection of non-genotoxic hepatocarcinogens and prediction of their mechanism of action in rats using gene marker sets
【24h】

Detection of non-genotoxic hepatocarcinogens and prediction of their mechanism of action in rats using gene marker sets

机译:使用基因标记集检测大鼠非遗传毒性肝致癌物并预测其作用机理

获取原文
           

摘要

Several studies have successfully detected hepatocarcinogenicity in rats based on gene expression data. However, prediction of hepatocarcinogens with certain mechanisms of action (MOAs), such as enzyme inducers and peroxisome proliferator-activated receptor α (PPARα) agonists, can prove difficult using a single model and requires a highly toxic dose. Here, we constructed a model for detecting non-genotoxic (NGTX) hepatocarcinogens and predicted their MOAs in rats. Gene expression data deposited in the Open Toxicogenomics Project-Genomics Assisted Toxicity Evaluation System (TG-GATEs) was used to investigate gene marker sets. Principal component analysis (PCA) was applied to discriminate different MOAs, and a support vector machine algorithm was applied to construct the prediction model. This approach identified 106 probe sets as gene marker sets for PCA and enabled the prediction model to be constructed. In PCA, NGTX hepatocarcinogens were classified as follows based on their MOAs: cytotoxicants, PPARα agonists, or enzyme inducers. The prediction model detected hepatocarcinogenicity with an accuracy of more than 90% in 14- and 28-day repeated-dose studies. In addition, the doses capable of predicting NGTX hepatocarcinogenicity were close to those required in rat carcinogenicity assays. In conclusion, our PCA and prediction model using gene marker sets will help assess the risk of hepatocarcinogenicity in humans based on MOAs and reduce the number of two-year rodent bioassays.
机译:根据基因表达数据,数项研究已成功检测出大鼠肝癌的致癌性。但是,使用单一模型很难预测具有某些作用机制(MOA)的肝致癌物,例如酶诱导剂和过氧化物酶体增殖物激活的受体α(PPARα)激动剂,并且需要剧毒剂量。在这里,我们构建了一种检测非遗传毒性(NGTX)肝致癌物的模型,并预测了它们在大鼠中的MOA。使用开放毒理学基因组计划-基因组学辅助毒性评估系统(TG-GATEs)中存放的基因表达数据来研究基因标记集。应用主成分分析(PCA)来区分不同的MOA,并使用支持向量机算法构建预测模型。该方法将106个探针集识别为PCA的基因标记集,并能够构建预测模型。在PCA中,NGTX的肝致癌物基于其MOA分为以下类别:细胞毒素,PPARα激动剂或酶诱导剂。该预测模型在14天和28天重复剂量研究中检测出肝癌致癌性,其准确性超过90%。此外,能够预测NGTX肝癌致癌性的剂量接近于大鼠致癌性试验所需的剂量。总之,我们的PCA和使用基因标记集的预测模型将有助于基于MOA评估人类肝癌的风险,并减少两年啮齿动物生物测定的次数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号